Invention Grant
- Patent Title: Pyrazine derivatives
-
Application No.: US15310337Application Date: 2015-05-12
-
Publication No.: US09856237B2Publication Date: 2018-01-02
- Inventor: Akinobu Maruyama , Susumu Takeuchi , Yoshimasa Takahashi
- Applicant: TEIJIN PHARMA LIMITED
- Applicant Address: JP Tokyo
- Assignee: Teijin Pharma Limited
- Current Assignee: Teijin Pharma Limited
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2014-099677 20140513
- International Application: PCT/JP2015/063654 WO 20150512
- International Announcement: WO2015/174417 WO 20151119
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D403/14 ; C07D401/14 ; C07D409/14

Abstract:
Provided is a novel pyrazine derivative represented by the following formula (I) or a pharmaceutically acceptable salt thereof, or a solvate thereof which is useful for treating or preventing diseases in which URAT1 is involved, including gout, hyperuricemia, hypertension, renal diseases such as interstitial nephritis and the like, diabetes, arteriosclerosis, Lesch-Nyhan syndrome, and the like.
Public/Granted literature
- US20170152242A1 PYRAZINE DERIVATIVES Public/Granted day:2017-06-01
Information query